L-arginine availability regulates T-lymphocyte cell-cycle progression
about
Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune RegulationEpigenetics in myeloid derived suppressor cells: a sheathed sword towards cancermTOR inhibitors effects on regulatory T cells and on dendritic cellsTransplantation Tolerance Induction: Cell Therapies and Their MechanismsThe role of neutrophils in immune dysfunction during severe inflammationPaving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateHow Neutrophils Shape Adaptive Immune ResponsesThe impact of the myeloid response to radiation therapyHampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesCOX-2 and PGE2-dependent immunomodulation in breast cancerControl of the immune response by pro-angiogenic factorsMyeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implicationsImmune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differencesCrystal Structures of Complexes with Cobalt-Reconstituted Human Arginase IThe Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in TransplantationMyeloid-derived suppressor cells as regulators of the immune systemRegulatory dendritic cells: there is more than just immune activationGr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infectionThe Intercellular Metabolic Interplay between Tumor and Immune CellsLocal suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasisThe role of myeloid-derived suppressor cells in immune ontogenyMapping the immunosuppressive environment in uterine tumors: implications for immunotherapy.Overexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissueExtreme retinal remodeling triggered by light damage: implications for age related macular degeneration.The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput dataTumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.Chronic alcohol consumption enhances myeloid-derived suppressor cells in B16BL6 melanoma-bearing mice.Pegylated arginase I: a potential therapeutic approach in T-ALLGlutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation.Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.The protective role of myeloid-derived suppressor cells in concanavalin A-induced hepatic injuryComplex role for the immune system in initiation and progression of pancreatic cancer.L-arginine deprivation impairs Leishmania major-specific T-cell responses.Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progressionIndoleamine 2,3 dioxygenase and metabolic control of immune responses.IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and ToleranceAgeing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease.Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring
P2860
Q26741252-87ADF81E-481E-4EC7-8F94-A0DC3A8544D3Q26741623-C7700815-C2BD-4678-8870-B11D1E6520F0Q26744447-11B68D99-FFB0-4D92-AC76-34A31E4C597AQ26751022-48B5B86F-E6F6-49C0-9208-6E107CF7B83BQ26752629-7DB7B4C8-BA08-45FA-98A7-E6E62A5B9ABDQ26777205-DEE2AAE2-7D17-4C77-8834-A0A3157218F6Q26781286-F0C288B3-F0E4-4982-9716-9EF577274B8AQ26851643-2EEBF828-8222-406A-B740-A9EA323AD8C9Q26863418-C4B292F8-85DF-4E67-9938-046374850538Q26991991-E46A19F2-9AE1-4B22-89C3-D220E46D2D9BQ27003937-AA99AC3E-B67D-4057-B94B-CD5E3D89BC2AQ27004733-AA6243A2-D34F-4F84-97FB-41B54EA07E55Q27014189-9F57C0A4-AE32-4464-82F8-F0162CEDBE9AQ27027064-E325F741-6C79-4B8D-A3D6-40A447E84ECAQ27672035-6743D05E-2D77-49B4-A9B9-86ACBC69E792Q28077757-DE1844D8-4FC7-4BA5-8795-EAC29BC83F6DQ28131637-51130F73-FD20-41FD-840B-E83D0C86D66CQ28388235-62307FAF-2375-438F-B84E-C15128E6597FQ28390496-671366F5-7D34-4134-8200-37BA5F56CDA1Q28391079-68B1A423-8149-456D-BD6D-2F4DD9E1686EQ28475723-D48B9CFA-0B6A-42DA-9554-FAE179F100D0Q28654584-9450E0D7-24C3-44AA-84A4-7C487DC42436Q30578330-724BA3E7-E900-4848-8B97-D3037DD72408Q31139529-EC201BA2-A9AB-4FAF-B445-24A0996412D2Q33335156-71E8D088-C5E4-4FDD-8FBD-60B6CA6AD571Q33592056-2FB5BD75-3D6F-4E20-8B2E-DD73EB06E6C8Q33763653-24BAC4BD-CB79-46A2-A421-F914A193E40DQ33898612-C13C75A7-335B-4881-80B5-4FE3A5489653Q33944287-738DA283-D6C3-4260-83D3-AEC78C1BD969Q33965172-AAC3C3BD-1DA5-44E8-813E-2D18A9892163Q33978763-7A2CE89A-7A79-411B-80E6-5DA02AD5E7C7Q34090829-8B9C3FDB-9C9F-4CD6-8877-D8495B72151EQ34093784-C2A8233F-2469-429E-A49B-8DE49215290AQ34167773-C1094D7B-6077-45C7-B46F-B240BF7D1B72Q34168497-70B5EE93-0E72-4E0B-A622-82A76CDEB5D0Q34308495-F9AC1727-A742-4E38-9939-5D9001485622Q34512092-04A4C588-AAD3-40A2-B0F1-859E4403F0FFQ34517267-2DC0D161-E7FB-4237-8A11-976B2EAD91D1Q34541778-8479B064-8FC5-4C65-8A14-4286907A5726Q34557531-A8582BBF-BBE2-41CD-B0B0-661214B93137
P2860
L-arginine availability regulates T-lymphocyte cell-cycle progression
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
L-arginine availability regulates T-lymphocyte cell-cycle progression
@ast
L-arginine availability regulates T-lymphocyte cell-cycle progression
@en
type
label
L-arginine availability regulates T-lymphocyte cell-cycle progression
@ast
L-arginine availability regulates T-lymphocyte cell-cycle progression
@en
prefLabel
L-arginine availability regulates T-lymphocyte cell-cycle progression
@ast
L-arginine availability regulates T-lymphocyte cell-cycle progression
@en
P2093
P2860
P1433
P1476
L-arginine availability regulates T-lymphocyte cell-cycle progression
@en
P2093
Augusto C Ochoa
David G Quiceno
Paulo C Rodriguez
P2860
P304
P356
10.1182/BLOOD-2006-06-031856
P407
P577
2006-10-05T00:00:00Z